rofecoxib has been researched along with Bowel Diseases, Inflammatory in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reinisch, W | 1 |
| Miehsler, W | 1 |
| Dejaco, C | 1 |
| Harrer, M | 1 |
| Waldhoer, T | 1 |
| Lichtenberger, C | 1 |
| Vogelsang, H | 1 |
| Biancone, L | 1 |
| Tosti, C | 1 |
| De Nigris, F | 1 |
| Fantini, M | 1 |
| Pallone, F | 1 |
1 trial available for rofecoxib and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia.
Topics: Adult; Aged; Arthralgia; Arthritis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase In | 2003 |
1 other study available for rofecoxib and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel disease.
Topics: Adult; Aged; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Infla | 2003 |